Descriptive Statistics (n = 81)
| Characteristics | Value |
|---|---|
| SF-12 = SF-12 Health Survey. | |
| Demographic characteristics | |
| Age in years, % | |
| ≤40 | 31 |
| 41–50 | 41 |
| 51–60 | 13 |
| >60 | 5 |
| Sex (female), % | 79 |
| Ethnic/racial minority, % | 10 |
| Education, % | |
| <High school | 3 |
| High school degree | 19 |
| Partial college or 2-year degree | 34 |
| 4-year college degree | 26 |
| Graduate or professional degree | 18 |
| Comorbid medical conditions, % | |
| 0 | 74 |
| 1 | 14 |
| 2+ | 14 |
| Number of medications for all conditions, median | 3.0 |
| Functional status (SF-12), mean ± SD | |
| Physical component scale | 49.0 ± 10.9 |
| Mental component scale | 41.6 ± 11.6 |
| Depression characteristics (at study date) | |
| Patient Health Questionnaire (PHQ-9) total, mean ± SD | 8.4 ± 1.8 |
| Depression severity classification, % | |
| None | 29 |
| Mild | 37 |
| Moderate | 15 |
| Moderately severe | 17 |
| Severe | 2 |
| Treatment characteristics | |
| Medication prescribed, % | |
| Bupropion | 11 |
| Citalopram | 19 |
| Fluoxetine | 11 |
| Nefazodone | 5 |
| Paroxetine | 19 |
| Sertraline | 24 |
| Venlafaxine | 11 |
| Treatment duration, median weeks | 75 |
| Antidepressant adherence, mean ± SD | |
| Recent (doses taken in past 2 weeks), % | 85.0 ± 3.0 |
| General (Morisky score) | 0.89 ± 0.96 |
| Medication beliefs: general, mean score ± SD | |
| Overprescription | 2.8 ± 0.8 |
| Harmfulness | 2.1 ± 0.5 |
| Medication beliefs: antidepressant-specific, mean score ± SD | |
| Necessity | 3.6 ± 0.8 |
| Concerns | 2.5 ± 0.9 |